Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression [NA]

View source ↗

Summary

A clinical trial registry entry describing research on early brainwave biomarkers to guide personalized neuromodulation for treatment-resistant depression; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Major Depressive Disorder, Treatment Resistant Depression | NA | Status: NOT_YET_RECRUITING